Quantcast

East and Central Asia

Dr. Reddy’s to Acquire Select Anti-Allergy Brands from Glenmark in Russia, Ukraine, Kazakhstan and Uzbekistan  

HYDERABAD, India–(BUSINESS WIRE)–Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as

Posted in Asia, news | Leave a comment

Sinovac COVID-19 vaccine collaboration with Butantan approved by Brazilian regulator for Phase III Trial

Sinovac Biotech’s partnership with Butantan, a leading Brazilian producer of immunobiologic products and vaccines, has reached a milestone as it moved one step further to our commitment to developing vaccines for global use after getting the approval for Phase 3 trial from Brazilian National Regulatory Agency, Anvisa.

Posted in Asia, news | Tagged , , | 1 Comment

Sinovac ends Covid-19 affected first quarter 2020 with decerase in sales

Sinovac Biotech, a provider of biopharmaceutical producs in China, has reported sales for the first quarter of 2020 at $15.4 million, a decrease of 57.9% from $36.6 million in the prior year period, with a loss attributed to common shareholders of $7.4 million, in the same period.

Posted in Asia, news | 1 Comment

Zhejiang Hisun Pharmaceutical Co., Ltd.: Free of COVID-19, Governments Suggest Favipiravir

TAIZHOU, China–(BUSINESS WIRE)–#Avigan–Favipiravir is a broad-spectrum antiviral agent that inhibits the RNA-dependent RNA polymerase of RNA viruses. It has efficacy

Posted in Asia, news | Tagged , , | Leave a comment

Dr. Reddy’s Laboratories Limited announces filing of Annual Report on Form 20-F

HYDERABAD, India–(BUSINESS WIRE)–Dr. Reddy’s Laboratories Limited (BSE: 500124, NSE: DRREDDY, NYSE: RDY) today announced that its Annual Report on Form

Posted in Asia, news | Tagged | Leave a comment

Mylan and Lupin receive European marketing authorization for Nepexto, biosimilar Etanercept

Mylan and Lupin Limited have received from the European Commission (EC) marketing authorization for Nepexto, a biosimilar to Enbrel, for all indications of the reference product.

Posted in Asia, news | Tagged , , , , , | Leave a comment

FDA Accepts Shionogi’s Supplemental New Drug Application with Priority Review for FETROJA® (cefiderocol) for the Treatment of Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia

OSAKA, Japan & FLORHAM PARK, N.J.–(BUSINESS WIRE)–Shionogi & Co., Ltd. (hereafter “Shionogi”) today announced the U.S. Food and Drug Administration

Posted in Asia, news | Tagged , , | Leave a comment

Takeda Receives Positive CHMP Opinion for Pre-Filled Syringe Presentation of TAKHZYRO® (lanadelumab) for Use as a Preventive Treatment for Hereditary Angioedema Attacks

Validation of Type II Variation will allow Takeda to commence launches in Europe later this year The pre-filled syringe presentation

Posted in Asia, news | Tagged , | Leave a comment

Vetter Wins Axia Best Managed Companies Award

Seal of quality for outstanding corporate management Analysis of the areas of strategy, innovation, corporate culture and finance Comprehensive three-stage

Posted in Asia, news | Tagged | Leave a comment

Sinovac secures $15M for COVID-19 vaccine dvelopment

Advantech Capital and Vivo Capital have invested $15 million in Sinovac Research and Development Co., Ltd. (“Sinovac R&D”), a wholly owned subsidiary of Sinovac, to further the development of an inactivated vaccine against COVID-19 named CoronaVac.

Posted in Asia, news | Tagged , , | Leave a comment